Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

RAHWAY, N.J., August 29, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630.

Some have dabbled in the art of do-it-yourself shifting, while others have made it a point to only offer a manual transmission on their hotter, more performance-oriented models to the glee of ...

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had ...

The good news, according to the Merck Veterinary Manual, is with proper treatment 68% to 92% of dogs infected with parvo eventually recover. Here is what you need to know about how dogs catch parvo, ...

According to the Merck Veterinary Manual, doxycycline dosage for dogs is usually 5 to10 mg per kilogram of body weight. Depending on the condition being treated and its severity, it may be given once ...